Abstract
The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Current Diabetes Reviews
Title: Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Volume: 6 Issue: 1
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Diabetes mellitus, morbidity, &, mortality, cardiovascular / Cancer / Neurodegenrative complications, socioeconomical burden, healthcare, predictive diagnosis, preventive measures, personalized medicine, healthcare providers, policymakers
Abstract: The worldwide epidemic scale of Diabetes mellitus (DM) has been underestimated for a long time. Currently every 10 seconds one patient dies of diabetes-related pathologies. Given the high risk and prevalence of secondary complications as well as individual predisposition to target organ injury, DM is one of the best examples for the application of predictive diagnostics aimed at preventive measures and personalized treatment. Generally, there are three levels desirable for pre- and Diabetes care:
1st level: prediction of the predisposition early in childhood
2nd level: prediction of early/premature aging and pre-stages of Diabetes
3rd level: prediction of Diabetes-related complications - cardiovascular, neurodegenerative and cancer diseases frequently developed in Diabetics.
Predictive diagnosis is considered as the basis for targeted preventive measures and consequent development of individualized treatment approaches. Communication among the professionals e.g. healthcare providers, policy-makers, educators, obligatorily involved in the overall process to improve (pre)Diabetes care is of paramount importance.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment, Current Diabetes Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339910790442637
DOI https://dx.doi.org/10.2174/157339910790442637 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors
Current Neuropharmacology Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Effects of Mulberry on The Central Nervous System: A Literature Review
Current Neuropharmacology Hypothalamic Glucose Sensing and Glycaemic Disease
Current Diabetes Reviews Gait-Related Strategies for the Prevention of Plantar Ulcer Development in the High Risk Foot
Current Diabetes Reviews BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients
Recent Patents on Anti-Cancer Drug Discovery TRP Channels as Targets for Therapeutic Intervention in Obesity: Focus on TRPV1 and TRPM5
Current Topics in Medicinal Chemistry Relationships of Birthweight and Postnatal Growth with Metabolic Risk Factors in Junior School Children in Korea
Current Hypertension Reviews Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders
CNS & Neurological Disorders - Drug Targets Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics The New Adipose Tissue and Adipocytokines
Current Diabetes Reviews Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Mechanisms of Neurodegeration in Type 2 Diabetes and the Neuroprotective Potential of Dipeptidyl Peptidase 4 Inhibitors
Current Medicinal Chemistry Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice
Current Stem Cell Research & Therapy Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism Different Pharmacokinetic Responses to an Acute Dose of Inorganic Nitrate in Patients with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Advanced Glycation End Products and Insulin Resistance
Current Pharmaceutical Design Antisense Oligonucleotides for the Treatment of Dyslipidemia
Current Pharmaceutical Design The Nitric Oxide Signaling Pathway in the Penis
Current Pharmaceutical Design